(Total Views: 493)
Posted On: 04/09/2020 11:11:45 AM
Post# of 155004
Re: ClosetInvestor #26539
Agree fully. Great news, but won't make FDA move swifter.
Speed of enrollment. Not that fast as NP thinks or we hope.
Doctors are going to chose for the EIND for their patients and not for the 2 out of 3 chance of getting Leronlimab under the trial.
Speed of enrollment. Not that fast as NP thinks or we hope.
Doctors are going to chose for the EIND for their patients and not for the 2 out of 3 chance of getting Leronlimab under the trial.
(0)
(0)
